口腔癌腫瘤特性與治療方式對存活復發轉移之相關性

The Correlation among Therapies, Survival and Recurrence by the Characters of Oral Cancer Tumor

10.6202/THJ-2013-09-14

陳淑賢(Shu-Hsien Chen)；蔡佩晏(Pei-Yien Tsai)；林知瑩(Chih-Ying Lin)；周玉書(Ji-Sho Chou)

國際疾病分類碼 ； 合併電化療 ； 腫瘤切源距離 ； 淋巴結轉移 ； International classification of diseases code ； Combined with chemotherapy ； Source distance ； Lymph node metastasis of tumor

慈惠學報

9期（2013 / 12 / 01）

174 - 187

繁體中文

This research aims at understanding of oral cancer patients under tumor characteristics and different medical treatments, respectively. We discuss the survival, relapse rate generated by comparing the differences after completely removed the tumor by surgery or electro-chemotherapy and combined therapy in different ways, The data resource from the Taichung Veterans General Hospital clinical records cases, studies during the 2000 to 2010 year. Use of international classification of disease codes ICD-10 extract with clinical records and pathological biopsy of oral cancer patients. We find the results as a total of 898 through to the analysis of the study. The patients gender predominance of males (93.8%), females have only 6.2%, the average age for 51.95 years. Average tumor size was 3.11 centimeters; tumor cut average source distance is 4.33 mm, the tumor source distance 20 mm; number of lymph node metastasis of averages to less than 1, maximum value of 14. The correlations of patients relapse and metastasis and survival status are described with Chi-square test analysis of and Kaplan-Meier of survival analysis. By the way, Log-Rank verification are adopted to estimated five-year survival rate of patients with oral cancer patient survival. The surgical excision with highest combined radiation therapy and chemotherapy is about 40.0%. Only for combined chemotherapy and radiation therapy patient survival rates are lower than 50%; under the Chi-square test, medical treatments and survival of usage patterns in a significant way and transfer (P＜0.001). This study finds that treatment and recurrence, metastasis and survival are obviously related to the clinical care, will respond to the patient's physiological and psychological level. Thus, to improve the quality of care is the mean purpose to up raise the survival of oral cancer patients.

This research aims at understanding of oral cancer patients under tumor characteristics and different medical treatments, respectively. We discuss the survival, relapse rate generated by comparing the differences after completely removed the tumor by surgery or electro-chemotherapy and combined therapy in different ways, The data resource from the Taichung Veterans General Hospital clinical records cases, studies during the 2000 to 2010 year. Use of international classification of disease codes ICD-10 extract with clinical records and pathological biopsy of oral cancer patients. We find the results as a total of 898 through to the analysis of the study. The patients gender predominance of males (93.8%), females have only 6.2%, the average age for 51.95 years. Average tumor size was 3.11 centimeters; tumor cut average source distance is 4.33 mm, the tumor source distance 20 mm; number of lymph node metastasis of averages to less than 1, maximum value of 14. The correlations of patients relapse and metastasis and survival status are described with Chi-square test analysis of and Kaplan-Meier of survival analysis. By the way, Log-Rank verification are adopted to estimated five-year survival rate of patients with oral cancer patient survival. The surgical excision with highest combined radiation therapy and chemotherapy is about 40.0%. Only for combined chemotherapy and radiation therapy patient survival rates are lower than 50%; under the Chi-square test, medical treatments and survival of usage patterns in a significant way and transfer (P＜0.001). This study finds that treatment and recurrence, metastasis and survival are obviously related to the clinical care, will respond to the patient's physiological and psychological level. Thus, to improve the quality of care is the mean purpose to up raise the survival of oral cancer patients.

1. Bernardi, D,Barzan, L,Franchin, G,Cinelli, R,Balestreri, L,Tirelli, U,Vaccher, E(2005).Treatment of head and neck cancer in elderly patients: state of the art and guidelines.Critical Reviews in Oncology –Hematology,53(1),71-80.
2. Herchenhorn, D,Dias, FL(2004).Advances in radiochemotherapy in the treatment of head and neck cancer.Revista do Hospital das Clinicans; Faculdade de Medicina Da Universidade de Sao Paulo,59(1),39-46.
3. IARC(1986).Betel-quid and areca-nut chewing.Lyon:International Agency for Research on Cancer Monographs.
4. Rusthoven, Kyle E,Raben, David,Song, John I,Kane, Madeleine,Altoos, Taghrid,Chen, Changhu(2010).Survival and Patterns of Relapse in Patients With Oral Tongue Cancer.Journal of Oral and Maxillofacial Surgery,68(3),6.
5. Sanderson, RJ,Ironside, JAD(2002).Squamous Cell carcinoma of Head and Neck.British Medical of Journal,325(12),822-827.
6. Witt, ME(1998).Radiation and chemotherapy as combined treatment foradvanced head and neck cancer.Medsurg Nursing,7(3),159-164.
7. Woolgar, JA,Rogers, S,West, CR,Errington, RD,Brown, JS,Vaughan, ED(1999).Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection.Oral Oncology,35(3),257-265.
8. Wu, GH,Boncher, BJ,Chiu, YJ(2009).Impact of chewing betel nut (Areca Catechu) on liver cirrhosis and hepatocellular carcinoma : a populationbased study from an area with a high prevalence of hepatitis B and C infections.Public Health Nutrition,12,129-135.
9. 江季亭,林恕德,蘇哲俊,蔡國陽,連怡斌,黃耀輝,張尊國(2009)。土壤重金屬鎳含量與口腔癌發生率之空間相關性探討。農業工程學報，55(19)，19-34。
10. 何佩珊(2002)。高雄醫學大學牙醫學研究所。
11. 林曜祥,任益民,李日清,林釗正,王炳龍(2002)。台灣地區頭頸癌概況。中華民國耳鼻喉科醫學雜誌，37(3)，176-182。
12. 陳金勝,蔡國陽,洪敦杰(2005)。頸部淋巴結大小及轉移對口腔癌患者存活率的影響。中華牙醫學雜誌（中文版），1(1)，25-31。
13. 詹日全,黃穰基,潘超群,王仲祺,王景平,劉時安(2007)。口腔癌治療後影響局部復發之相關因素分析。臺灣耳鼻喉頭頸外科雜誌，42(4)，115-273。

1. 羅珮娟,楊佩瑄,黃綉雲,林貴香,林美瑩(2017)。口腔癌病人接受腫瘤個案管理照護之未完成治療原因及存活分析。腫瘤護理雜誌，17(1)，31-48。